BDPT
BIOADAPTIVES, INC.
Key Financials
Revenue
$18278
↑ 44.3%
Operating Income
$-1042173
↓ 73.1%
Total Assets
$225901.00
↓ 13.7%
EPS (Diluted)
$-0.15
↓ 36.4%
Gross Profit
$12497
↑ 210.1%
Net Income
$-1557898
↓ 73.3%
Total Liabilities
$2.4M
↑ 36.5%
Shareholders' Equity
$-2130056.00
↓ 45.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 9/3/2026 | View on SEC |
| 10-Q | 8/19/2026 | View on SEC |
| NT 10-Q | 8/14/2026 | View on SEC |
| 4 | 8/4/2026 | View on SEC |
| 4 | 7/6/2026 | View on SEC |
| 4 | 6/3/2026 | View on SEC |
| 10-Q | 5/15/2026 | View on SEC |
| 4 | 5/5/2026 | View on SEC |
| 10-K | 4/14/2026 | View on SEC |
| 4 | 4/3/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BDPT |
| Company Name | BIOADAPTIVES, INC. |
| CIK | 1575142 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (702) 659-8829 |